Hogan Lovells 2024 Election Impact and Congressional Outlook Report
David M. Foster
Partner Litigation, Arbitration, and Employment
Languages
English, Spanish
David has particularly deep experience representing pharmaceutical companies and other clients in the life sciences sector. For example, he has defended a major international pharmaceutical company in some of the most of high-profile class actions in recent years concerning drug pricing and marketing. He also has represented life sciences clients in price-reporting disputes, commercial litigation, antitrust suits, and investigations by the Department of Justice and state attorneys general.
David also defends clients in cross-border disputes, including human rights lawsuits concerning alleged labor conditions in international supply chains. For example, he has successfully defended multiple putative class actions brought under the Alien Tort Statute and the Trafficking Victims Protection Reauthorization Act (TVPRA).
In 2005, David received Harvard Law School's Victor Brudney Prize for best paper on the topic of corporate governance. Before attending law school, David worked for a consulting firm that specialized in providing expert testimony for antitrust litigation.
Representation of pharmaceutical company in multidistrict litigation and other class actions involving claims under RICO, antitrust laws, and state consumer protection statutes.
Representation of major U.S. food company in defense of Alien Tort Statute claims involving alleged labor conditions on cocoa farms in the Ivory Coast, culminating with win in U.S. Supreme Court.
Representation of major technology company in lawsuit asserting violations of TVPRA relating to allegations concerning mining activity in Africa, resulting in dismissal of claims at pleading stage.
Representation of leading food company in defense of TVPRA claims relating to allegations concerning farming activity in Africa, resulting in dismissal of claims at pleading stage.
Representation of lender in lawsuits in which plaintiffs and bankruptcy trustee alleged client was liable for US$2.3bn in judgments against health care companies, resulting in summary judgment win.
Representation of leading global pharmaceutical company in defense of government investigations at both state and federal level.
Representation of clinical laboratory in suit alleging violations of Lanham Act, anti-kickback statute, and unfair competition laws.
Representation of life sciences companies in pharmaceutical pricing matters, including disputes and investigations relating to Medicaid rebates and the 340B program.
Representation of leading insurance company in multidistrict litigation arising out of alleged bid-rigging by insurance brokers.
Representation of premier media company in defending lawsuit that sought to enjoin airing of television documentary.
Member of team that represented D.C. homeowners in suits asserting violations of consumer protection statutes against perpetrators of foreclosure rescue scam, resulting in US$3.3m jury verdict.